A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction

Arman Rahmim, C. Ross Schmidtlein, Andrew Jackson, Sara Sheikhbahaei, Charles Marcus, Saeed Ashrafinia, Madjid Soltani, Rathan M. Subramaniam

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Oncologic PET images provide valuable information that can enable enhanced prognosis of disease. Nonetheless, such information is simplified significantly in routine clinical assessment to meet workflow constraints. Examples of typical FDG PET metrics include: (i) SUVmax, (2) total lesion glycolysis (TLG), and (3) metabolic tumor volume (MTV). We have derived and implemented a novel metric for tumor quantification, inspired in essence by a model of generalized equivalent uniform dose as used in radiation therapy. The proposed metric, denoted generalized effective total uptake (gETU), is attractive as it encompasses the abovementioned commonly invoked metrics, and generalizes them, for both homogeneous and heterogeneous tumors, using a single parameter a. We evaluated this new metric for improved overall survival (OS) prediction on two different baseline FDG PET/CT datasets: (a) 113 patients with squamous cell cancer of the oropharynx, and (b) 72 patients with locally advanced pancreatic adenocarcinoma. Kaplan-Meier survival analysis was performed, where the subjects were subdivided into two groups using the median threshold, from which the hazard ratios (HR) were computed in Cox proportional hazards regression. For the oropharyngeal cancer dataset, MTV, TLG, SUVmax, SUVmean and SUVpeak produced HR values of 1.86, 3.02, 1.34, 1.36 and 1.62, while the proposed gETU metric for a = 0.25 (greater emphasis on volume information) enabled significantly enhanced OS prediction with HR = 3.94. For the pancreatic cancer dataset, MTV, TLG, SUVmax, SUVmean and SUVpeak resulted in HR values of 1.05, 1.25, 1.42, 1.45 and 1.52, while gETU at a = 3.2 (greater emphasis on SUV information) arrived at an improved HR value of 1.61. Overall, the proposed methodology allows placement of differing degrees of emphasis on tumor volume versus uptake for different types of tumors to enable enhanced clinical outcome prediction.

Original languageEnglish (US)
Pages (from-to)227-242
Number of pages16
JournalPhysics in Medicine and Biology
Volume61
Issue number1
DOIs
StatePublished - Dec 4 2015

Fingerprint

Tumor Burden
Glycolysis
Oropharyngeal Neoplasms
Neoplasms
Squamous Cell Neoplasms
Survival
Workflow
Kaplan-Meier Estimate
Survival Analysis
Pancreatic Neoplasms
Adenocarcinoma
Radiotherapy
Datasets

Keywords

  • heterogeneity
  • metric
  • PET
  • prediction
  • quantification
  • survival analysis
  • texture

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Cite this

A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction. / Rahmim, Arman; Schmidtlein, C. Ross; Jackson, Andrew; Sheikhbahaei, Sara; Marcus, Charles; Ashrafinia, Saeed; Soltani, Madjid; Subramaniam, Rathan M.

In: Physics in Medicine and Biology, Vol. 61, No. 1, 04.12.2015, p. 227-242.

Research output: Contribution to journalArticle

Rahmim, Arman ; Schmidtlein, C. Ross ; Jackson, Andrew ; Sheikhbahaei, Sara ; Marcus, Charles ; Ashrafinia, Saeed ; Soltani, Madjid ; Subramaniam, Rathan M. / A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction. In: Physics in Medicine and Biology. 2015 ; Vol. 61, No. 1. pp. 227-242.
@article{f8cfd10ee443467b93e5391456d7f50c,
title = "A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction",
abstract = "Oncologic PET images provide valuable information that can enable enhanced prognosis of disease. Nonetheless, such information is simplified significantly in routine clinical assessment to meet workflow constraints. Examples of typical FDG PET metrics include: (i) SUVmax, (2) total lesion glycolysis (TLG), and (3) metabolic tumor volume (MTV). We have derived and implemented a novel metric for tumor quantification, inspired in essence by a model of generalized equivalent uniform dose as used in radiation therapy. The proposed metric, denoted generalized effective total uptake (gETU), is attractive as it encompasses the abovementioned commonly invoked metrics, and generalizes them, for both homogeneous and heterogeneous tumors, using a single parameter a. We evaluated this new metric for improved overall survival (OS) prediction on two different baseline FDG PET/CT datasets: (a) 113 patients with squamous cell cancer of the oropharynx, and (b) 72 patients with locally advanced pancreatic adenocarcinoma. Kaplan-Meier survival analysis was performed, where the subjects were subdivided into two groups using the median threshold, from which the hazard ratios (HR) were computed in Cox proportional hazards regression. For the oropharyngeal cancer dataset, MTV, TLG, SUVmax, SUVmean and SUVpeak produced HR values of 1.86, 3.02, 1.34, 1.36 and 1.62, while the proposed gETU metric for a = 0.25 (greater emphasis on volume information) enabled significantly enhanced OS prediction with HR = 3.94. For the pancreatic cancer dataset, MTV, TLG, SUVmax, SUVmean and SUVpeak resulted in HR values of 1.05, 1.25, 1.42, 1.45 and 1.52, while gETU at a = 3.2 (greater emphasis on SUV information) arrived at an improved HR value of 1.61. Overall, the proposed methodology allows placement of differing degrees of emphasis on tumor volume versus uptake for different types of tumors to enable enhanced clinical outcome prediction.",
keywords = "heterogeneity, metric, PET, prediction, quantification, survival analysis, texture",
author = "Arman Rahmim and Schmidtlein, {C. Ross} and Andrew Jackson and Sara Sheikhbahaei and Charles Marcus and Saeed Ashrafinia and Madjid Soltani and Subramaniam, {Rathan M.}",
year = "2015",
month = "12",
day = "4",
doi = "10.1088/0031-9155/61/1/227",
language = "English (US)",
volume = "61",
pages = "227--242",
journal = "Physics in Medicine and Biology",
issn = "0031-9155",
publisher = "IOP Publishing Ltd.",
number = "1",

}

TY - JOUR

T1 - A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction

AU - Rahmim, Arman

AU - Schmidtlein, C. Ross

AU - Jackson, Andrew

AU - Sheikhbahaei, Sara

AU - Marcus, Charles

AU - Ashrafinia, Saeed

AU - Soltani, Madjid

AU - Subramaniam, Rathan M.

PY - 2015/12/4

Y1 - 2015/12/4

N2 - Oncologic PET images provide valuable information that can enable enhanced prognosis of disease. Nonetheless, such information is simplified significantly in routine clinical assessment to meet workflow constraints. Examples of typical FDG PET metrics include: (i) SUVmax, (2) total lesion glycolysis (TLG), and (3) metabolic tumor volume (MTV). We have derived and implemented a novel metric for tumor quantification, inspired in essence by a model of generalized equivalent uniform dose as used in radiation therapy. The proposed metric, denoted generalized effective total uptake (gETU), is attractive as it encompasses the abovementioned commonly invoked metrics, and generalizes them, for both homogeneous and heterogeneous tumors, using a single parameter a. We evaluated this new metric for improved overall survival (OS) prediction on two different baseline FDG PET/CT datasets: (a) 113 patients with squamous cell cancer of the oropharynx, and (b) 72 patients with locally advanced pancreatic adenocarcinoma. Kaplan-Meier survival analysis was performed, where the subjects were subdivided into two groups using the median threshold, from which the hazard ratios (HR) were computed in Cox proportional hazards regression. For the oropharyngeal cancer dataset, MTV, TLG, SUVmax, SUVmean and SUVpeak produced HR values of 1.86, 3.02, 1.34, 1.36 and 1.62, while the proposed gETU metric for a = 0.25 (greater emphasis on volume information) enabled significantly enhanced OS prediction with HR = 3.94. For the pancreatic cancer dataset, MTV, TLG, SUVmax, SUVmean and SUVpeak resulted in HR values of 1.05, 1.25, 1.42, 1.45 and 1.52, while gETU at a = 3.2 (greater emphasis on SUV information) arrived at an improved HR value of 1.61. Overall, the proposed methodology allows placement of differing degrees of emphasis on tumor volume versus uptake for different types of tumors to enable enhanced clinical outcome prediction.

AB - Oncologic PET images provide valuable information that can enable enhanced prognosis of disease. Nonetheless, such information is simplified significantly in routine clinical assessment to meet workflow constraints. Examples of typical FDG PET metrics include: (i) SUVmax, (2) total lesion glycolysis (TLG), and (3) metabolic tumor volume (MTV). We have derived and implemented a novel metric for tumor quantification, inspired in essence by a model of generalized equivalent uniform dose as used in radiation therapy. The proposed metric, denoted generalized effective total uptake (gETU), is attractive as it encompasses the abovementioned commonly invoked metrics, and generalizes them, for both homogeneous and heterogeneous tumors, using a single parameter a. We evaluated this new metric for improved overall survival (OS) prediction on two different baseline FDG PET/CT datasets: (a) 113 patients with squamous cell cancer of the oropharynx, and (b) 72 patients with locally advanced pancreatic adenocarcinoma. Kaplan-Meier survival analysis was performed, where the subjects were subdivided into two groups using the median threshold, from which the hazard ratios (HR) were computed in Cox proportional hazards regression. For the oropharyngeal cancer dataset, MTV, TLG, SUVmax, SUVmean and SUVpeak produced HR values of 1.86, 3.02, 1.34, 1.36 and 1.62, while the proposed gETU metric for a = 0.25 (greater emphasis on volume information) enabled significantly enhanced OS prediction with HR = 3.94. For the pancreatic cancer dataset, MTV, TLG, SUVmax, SUVmean and SUVpeak resulted in HR values of 1.05, 1.25, 1.42, 1.45 and 1.52, while gETU at a = 3.2 (greater emphasis on SUV information) arrived at an improved HR value of 1.61. Overall, the proposed methodology allows placement of differing degrees of emphasis on tumor volume versus uptake for different types of tumors to enable enhanced clinical outcome prediction.

KW - heterogeneity

KW - metric

KW - PET

KW - prediction

KW - quantification

KW - survival analysis

KW - texture

UR - http://www.scopus.com/inward/record.url?scp=84951056977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951056977&partnerID=8YFLogxK

U2 - 10.1088/0031-9155/61/1/227

DO - 10.1088/0031-9155/61/1/227

M3 - Article

C2 - 26639024

AN - SCOPUS:84951056977

VL - 61

SP - 227

EP - 242

JO - Physics in Medicine and Biology

JF - Physics in Medicine and Biology

SN - 0031-9155

IS - 1

ER -